Stock Exchange Releases
Biohit Oyj Financial Calendar, Biohit Oyj’s Financial Reporting and Annual General Meeting in 2020
Biohit Oyj Financial calendar, November 29, 2019 at 4:00 pm local time (EET)
Read moreBIOHIT GROUP HALF YEAR FINANCIAL REPORT 2019
Biohit Oyj Half Year Financial Report 14 August 2019 at 9:30 am local time (EET)
Read moreTwo clinical trials with Acetium® capsule for prevention of migraine-type headache have been concluded
Biohit Oyj Stock Exchange Release August 9th 2019 at 15.30 pm local time (EET)
Read moreBiohit Oyj B-shares Subscribed with Stock Options I 2013
Biohit Oyj Stock Exchange Release June 12, 2019 at 13.15 a.m. (EEST) A total number of 88,552 new Biohit Oyj B-shares have been subscribed for with stock options I 2013 between 12 February 2019 and 31 May 2019. These shares have been entered into the Trade Register on June 12, 2019, as of which date the…
Read moreBiohit Plc - Managers' transactions - Söderström
Person subject to the notification requirement Name: Söderström, Daniela Position: Other senior manager Issuer: Biohit Plc LEI: 74370089ATTSNBXJVT29 Notification type: INITIAL NOTIFICATION Reference number: 74370089ATTSNBXJVT29_20190603065401_4 Transaction date: 2019-05-29 Instrument type: SHARE ISIN: FI0009005482 Nature of the transaction: SUBSCRIPTION (X) Linked to stock option programme Transaction details (1): Volume: 25 000 Unit price: 2.2766…
Read moreMay is the month for esophageal, intestinal and gastric health - How to prevent diseases and diagnose them early?
Press Release 20.5.2019 at 10.30 local time (EET) May is devoted to increase the awareness of digestive diseases and their prevention. Colorectal cancer is one of the most common types of cancer among the Finnish people. Biohit Oyj and UEG (United European Gastroenterology) encourage to prevention of these cancers by testing the intestinal and gastric…
Read moreConstitutive meeting of Biohit Oyj’s Board of Directors
Biohit Oyj: Other information disclosed according to the rules of the Exchange April 25, 2019 at 9:30 am local time (EEST) Biohit Oyj’s Board of Directors has in its meeting yesterday elected Mr Osmo Suovaniemi as the Chairman of the Board of Directors. Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi…
Read moreDecisions of the Annual General Meeting of Biohit Oyj
Biohit Oyj: Decisions of the Annual General Meeting April 24, 2019 at 7:30 pm local time (EET) The Annual General Meeting (AGM) of Biohit Oyj held on Wednesday April 24, 2019 approved the financial statements of the parent company and the consolidated financial statements, and discharged the members of the Board of Directors and the…
Read moreAcetium® lozenge for smoking intervention will shortly be distributed in Italy within Difar Consumer Care® product division
Press release April 17th, 2019 at 09.30 local time (EEST) Biohit Oyj and Difar Distribuzione s.r.l have signed an agreement for the distribution of the Acetium® lozenge in Italy. CEO Semi Korpela, Biohit Oyj: “We are pleased to get the Acetium® lozenge available also in Italy. Acetium® lozenge for smoking intervention is one of Biohit’s…
Read moreAcetium® lozenge for smoking intervention will be available in Thailand during the year 2019
Press release 11th April 2019 at 09.30 local time (EEST) Biohit Oyj and Precision Health Co., Ltd have signed an agreement for the distribution of the Acetium lozenge in Thailand. The effectiveness of Acetium® lozenge in smoking intervention has been evaluated in two clinical trials.1- 2 When regularly used concomitantly with every smoked cigarette, eventually the…
Read more